Lacosamide Extended-Release Tablets(Taizhou Overseas Pharma)

拉考沙胺缓释片(越洋医药)

Report date: 2025/08/01 17:18:55

Base Information

Drug NameLacosamide Extended-Release Tablets(Taizhou Overseas Pharma)
Drug Alias NameHarkoseride拉克酰胺Lacosamidum拉考沙胺缓释片(2.2类改良型)Lacosamida +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockersGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptorSodium channel alpha subunit
Therapy Area/IndicationsEpilepsies, PartialEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsEpilepsies, PartialEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A